1
Published 2013
Canadian Agency for Drugs and Technologies in Health
... by specialist physicians (podiatrists), non-specialists such as family physicians, or nurses or other allied...

2
by Brooker, Ann-Sylvia, Loshak, Hannah
Published 2020
CADTH
... by endocrinologists. More recently there has been a shift in the duty of responsibility toward community physicians...

3
Published 2013
Canadian Agency for Drugs and Technologies in Health
..., patients in rural or remote areas are unlikely to receive thrombolysis treatment unless remote physicians...

4
by Crain, Janet, Raj, Michael, Garland, Sarah, Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for patients with insomnia disorder from the perspective of family physicians, nurse practitioners...

5
by Brooker, Ann-Sylvia, Loshak, Hannah
Published 2020
CADTH
... by endocrinologists. More recently there has been a shift in the duty of responsibility toward community physicians...

6
by Crain, Janet, Raj, Michael, Garland, Sarah, Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for patients with insomnia disorder from the perspective of family physicians, nurse practitioners...

7
by Crain, Janet, MacPherson, Jennifer, Raj, Michael, Singh, Kavita
Published 2017
Canadian Agency for Drugs and Technologies in Health
... and implementation issues for antibiotic therapies from the perspective of family physicians (FPs), nurse...

8
Published 2011
Canadian Agency for Drugs and Technologies in Health

9
Published 2011
Canadian Agency for Drugs and Technologies in Health
... current practices of physicians and patients regarding the use of AAP combination and high-dose treatment...

10
Published 2011
Canadian Agency for Drugs and Technologies in Health
... current practices of physicians and patients regarding the use of AAP combination and high-dose treatment...

11
Published 2014
Canadian Agency for Drugs and Technologies in Health

12
Published 2014
Canadian Agency for Drugs and Technologies in Health

14
Published 2018
CADTH
... physician with experience in the diagnosis and management of GCA. A reduction in price...

15
Published 2018
CADTH
... physician with experience in the diagnosis and management of GCA. A reduction in price...

16
Published 2018
CADTH
... is prescribed by a physician with experience in the diagnosis and management of hereditary tyrosinemia type-1...

17
Published 2018
Canadian Agency for Drugs and Technologies in Health
... in patients with an established diagnosis of HT-1. The drug is prescribed by a physician with experience...

18
Published 2014
Canadian Agency for Drugs and Technologies in Health
... for the clinical effectiveness of formal PA prescriptions issued by a physician or nurse practitioner...

19
Published 2014
Canadian Agency for Drugs and Technologies in Health
... for the clinical effectiveness of formal PA prescriptions issued by a physician or nurse practitioner...

20
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... The diagnosis of HAE type I or II is made by a specialist physician who has experience in the diagnosis of HAE...